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Abstract 
Background: The use of crystal methamphetamine, erectile dysfunction medication (EDM), 
and amyl nitrite have been associated with sexual risk behaviour and HIV infection among 
gay and bisexual men (GBM).  
Objective: This paper describes an online prospective observational study of licit and illicit 
drug use among GBM  and explores baseline prevalence of drug use in this sample. 
Capturing these data poses challenges as participants are required to disclose potentially 
illegal behaviours in a geographically dispersed country. To address this issue, an entirely 
online and study specific methodology was chosen. 
Methods: Men living in Australia, aged 16.5 years of age or older, who identified as 
homosexual or bisexual or had sex with at least one man in the preceding 12 months were 
eligible to enrol.  
Results: Between September 2014 and July 2015, a total of 2251 participants completed the 
baseline questionnaire, of whom, 1711 (76.0%) consented to six monthly follow-up. The 
majority (65.7%) were recruited through Facebook targeted advertising. At baseline, over 
half (50.5%) the men reported the use of any illicit drug in the previous six months, and 
28.0% had used party drugs.  In the six months prior to enrolment, one-third had used amyl 
nitrite (32.1%), 21.8% had used EDM, and 12.0% had used crystal methamphetamine. 
Among the 1711 men enrolled into the cohort, 790 men had used none of these drugs. 
Conclusion: Ease of entry and minimal research burden on participants helped ensure 
successful recruitment into this online cohort study. Study outcomes will include the 
initiation and cessation of drug use, associated risk behaviors, and health consequences, over 
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time. Results will provide insights into the role of gay community networks in patterns of 
drug use among GBM.  
Key Words: automated methodology, cohort, drug use, gay and bisexual men, online 
methodology, online surveys 
Highlights 
 Over half of GBM in this sample reported the use of any illicit drug in the previous 
six months  
 Almost half indicating no use of crystal methamphetamine, amyl nitrite, and erectile 
dysfunction medication  
 The majority of GBM were recruited through Facebook targeted advertising 
 Online methodology facilitates confidential reporting of illicit behaviour 
 Sophisticated automation process can reduce labour and other costs associated with 
data collection 
 Automated digital recruitment and follow-up process allows participants to decide 
their own level of engagement and participation at each stage of the research  
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Background  
The prevalence of licit and illicit drug use among gay and bisexual men (GBM) is higher than 
in other population groups (Bolding, Hart, Sherr, & Elford, 2006; Cochran, Ackerman, Mays, 
& Ross, 2004; Hickson, Bonell, Weatherburn, & Reid, 2010; Lea et al., 2013b; Newcomb, 
Ryan, Greene, Garofalo, & Mustanski, 2014; Roxburgh, Lea, De Wit, & Degenhardt, 2015). 
In Australia, more than half of GBM reported recent illicit drug use (Lea et al., 2013b). One 
in twenty (5.6%) reported recent injection drug use (Lea et al., 2013a). Few studies have 
reported on incidence, or risk factors for, initiation and cessation of, or changes in, drug use 
over time, or on the harmful outcomes of such use, among Australian GBM. 
Associations between drug use and sexual risk behaviour among GBM 
Condomless anal intercourse with casual male partners (CLAIC) is the primary risk factor for 
HIV infection among GBM (Elford, 2006; Jin et al., 2009; Zablotska, Prestage, Middleton, 
Wilson, & Grulich, 2010). Drug use, particularly when used to enhance sexual pleasures has 
been associated with CLAIC and with incident HIV infection among GBM (Bolding et al., 
2006; Buchacz et al., 2005; DiFranceisco, Ostrow, & Chmiel, 1996; Koblin et al., 2003; 
McCabe, Hughes, Bostwick, West, & Boyd, 2009; Prestage, 2009; Prestage, Grierson, 
Bradley, Hurley, & Hudson, 2009a; Rusch, Lampinen, Schilder, & Hogg, 2004; Solomon, 
Kiang, Halkitis, Moeller, & Pappas, 2010). Specigfically, crystal methamphetamine and 
erectile dysfunctin medication (EDM), both used separately or in combonation, have been 
most strongly implicated with sexual risk behaviours and HIV infection (Prestage, Jin, 
Kippaz, Zablotska, Imrine, & Grulich, 2009b; Fisher, Reynolds, & Napper, 2010).  
Most studies to date have focused on drug use and HIV risk behaviours among GBM as a 
simple one-way association, often implying direct causality but lacking clear evidence. Far 
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less is known about the role of social, community, and interpersonal factors in predicting 
uptake, cessation, and harmful drug use.  
Research into motivations for drug use among GBM has typically focused on individual 
psychological factors including the effects of homophobia, social isolation, and sexual abuse 
(Hatzenbuehler, 2009; Stall et al., 2001). Participation in gay community networks has been 
associated with increased levels of drug use (Lea, Reynolds, & De Wit, 2013c). Participation 
in networks of sexually adventurous GBM in the context of intensive sex partying is a key 
factor in sexual risk behaviour and HIV infection (Halkitis & Palamar, 2008; Halkitis, 
Palamar, & Mukherjee, 2007; Mansergh et al., 2001; Prestage, 2009; Prestage et al., 2009a; 
Prestage et al., 2009b; Semple, Zians, Strathdee, & Patterson, 2009; Solomon et al., 2010). 
This suggests that relationships between sexual risk behaviour, HIV acquisition, and drug use 
among GBM are mediated by social and community networks and subcultural affiliations.  
Other drug-related harms and consequences 
Although less often explored, the prevalence of drug-related harms such as dependence and 
overdose is high (Bolding et al., 2006; Prestage et al., 2009b; Semple et al., 2009; Stall et al., 
2001; Zablotska et al., 2010). Social support provided by some gay community sexual 
networks can mediate individuals’ drug use to prevent associated harms (Bauermeister, 
2008). Further insights into specific behavioural practices and social networks may identify 
barriers to the adoption of harm reduction messages and inform better targeting of harm 
reduction programs within these networks. 
Attitudes and beliefs about drug use in gay communities 
Sexual practices among GBM are influenced by shared understandings of HIV risk and gay 
community norms, particularly those regarding ‘safe sex’ (Kippax, 1993). This may also be 
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true of drug-using behaviours and attitudes toward harm reduction. Further research is 
required about the role of specific gay community subcultures, and how engagement in 
particular sexual and social networks influences the initiation and cessation of drug use and 
changes in drug use over time.  
The shared understandings of risk and pleasure in relation to drug use and sex among GBM 
are likely to be key factors in their drug using behaviour. Broad attitudes toward drug use 
among GBM have been explored elsewhere (Halkitis, Fischgrund, & Parsons, 2005; Jerome, 
Halkitis, & Siconolfi, 2009; Palamar & Halkitis, 2006) but normative beliefs about drug use 
within Australian gay community networks have not been previously investigated.  
Study Aims 
In this paper, we describe the methodology and report baseline prevalence of licit and illicit 
drug use among men enrolled in the Following Lives Undergoing Change (Flux) study. 
Flux was established to: 
1. Identify individual and contextual factors associated with initiation and cessation of 
drug use and changes over time in patterns of sexual and drug use behaviours among 
GBM men. 
2. Describe the relationship between social and community norms and drug use 
behaviours and beliefs among GBM. 
3. To describe the role of particular gay community subcultures, and sexual and social 
networks, in relation to attitudes and beliefs about drug use and drug-use behaviours. 
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We developed sophisticated and automated procedures specific to this study. This paper will 
demonstrate the novel application of this methodology to address the study aims; and provide 
details of the characteristics of the cohort and their drug user profile.   
Methods 
The Flux study is being conducted nationally using online survey techniques. We 
systematically enrol and follow-up individual GBM to collect information about drug use, 
risk behaviour and associated harms, and gay community engagement. We obtained 
additional optional consent at enrolment for linkage to hospitalisation datasets to identify 
drug-related presentations, and to the national HIV registry to confirm prevalent and incident 
HIV infections. The Flux protocol and all supporting documentation have been approved by 
Human Research Ethics Committee of the University of New South Wales. 
Study design  
We enrolled a broad sample of GBM including both current users and non-users of illicit 
drugs at baseline. The study will monitor changes in drug use and associated harms, beliefs 
and attitudes, and engagement with gay community networks over time through self-
completion of online questionnaires at six monthly intervals. 
A unique integrated system of digitally linking individually tailored questionnaires, study 
databases, and communications with participants, was developed for this study and was 
named the Flux Automatic Management eSystem (FAME). It was designed to be specific to 
this study but can be adapted to other research projects.  
Power calculation and sample size  
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The event-driven approach was used for sample size calculations in order to compare the 
incidence of drug initation between men who reported CLAIC in the last 6 months and those 
who did not. To enable a 80% statistical powe to detect a two-fold increase in the incidence 
of drug initiation of amyl nitrite, erectile dysfuction medication or crystal methamphetamine, 
a minimum of 67 cases of initiation use of these drugs is required over a total of 540 person-
years of follow-up. Based on our previous studies, we assumed an incidence of 10 per 100 
person-years of initiation of these drugs (Prestage et al., 2009b) and a prevalence of 25% in 
men reporting CLAIC in the Gay Community Periodic Surveys (ongoing behavioural 
surveillance survey of GBM in Australia).  Therefore, we proposed to recruit 360 men who 
did not have a history of using these drugs at baseline with an average follow-up of 1.5 years.  
From the Health in Men study, around 75% of men reported a history of using any of the 
three drugs (Prestage et al., 2009a), hence the total sample size of 1440 men.   
Eligibility and participation  
Eligibility criteria for the study were being male, currently living in Australia and aged 16.5 
years or older, and identifying as a gay/homosexual or bisexual man or had sex with at least 
one man in the preceding twelve months. 
No incentives were provided to promote enrolment. Recruitment into the Flux study was 
achieved entirely online. Advertising through a wide range of social media was used to reach 
a diverse sample of GBM across Australia, with varying degrees of gay community 
engagement. These included: Popular gay and bisexual ’dating’ sites and apps; and 
Facebook. The study was also promoted through gay community events and organisations, 
with potential participants being provided a direct link to the study website. Advertising 
aimed to reach a broad sample of GBM [Appendix I] but some advertising was more targeted 
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to specifically attract drug use naïve (GBM who were not using drugs) participants 
[Appendix II].  
Enrollment commenced in September 2014 and was completed in July 2015.  Two-thirds 
(65.7%) were recruited through Facebook advertising, which obtained 286,346 views, with, 
on average, each person seeing the advertisement 2.74 times. There were 13,004 clicks on the 
advertised link that directed potential participants to the Flux study website.   
In total, 21,014 clicks were received on the study’s website and 6,810 clicked through to the 
consent form. Of these, 4,306 clicks were received past the first page of the consent form 
where they indicated their level of consent (six-monthly follow-up or baseline only). A total 
of 2943 people completed the consent form (six-monthly follow-up or baseline only) and 
2705 men commenced survey responses, of whom 2251 (83.2%) provided sufficiently 
complete baseline data for tracking trends in drug use over time. Of the 2251 participants 
who completed the baseline questionnaire, 1711 (76.0%) gave consent to follow-up at six-
monthly intervals. Of those who consented to follow-up, 1478 commenced the baseline 
questionnaire immediately, and 233 deferred their baseline entry and completed it at a later 
time. Of the 1711 participants who provided consent to follow-up, 1015 (59.3%) also 
provided any consent to data linkage. 
Measures 
Questionnaire items include: Demographic characteristics; social and community 
engagement with gay men; HIV and viral hepatitis status; licit and illicit drug use during 
lifetime and in the previous six months; drug use pleasures and harms; sexual behaviours; 
stigma and mental health; attitudes to gay community and drug use; and access to harm 
reduction resources and treatment services.  
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Previously used measures of drug use (Degenhardt, Day, Gilmour, & Hall, 2005), as well as 
additional items devised specifically for GBM are used, as well as our previously validated 
measures of sexual risk behaviour and engagement in gay community networks and 
subcultures (Jin et al., 2009; Zablotska, Kippax, Grulich, Holt, & Prestage, 2011). Measures 
of gay community engagement include two different kinds of measures: Scales measuring the 
extent of community engagement, and indicator variables for types of engagement (Kippax et 
al., 1998). The generalised anxiety disorder assessment (GAD7; Spitzer, Kroenke, Williams, 
& Löwe, 2006), the sexual sensation sensation-seeking (Kalichman, Heckman, & Kelly, 
1996), and the patient health questionnaire (PHQ9; Kroenke, Spitzer, & Williams, 2001) 
were also included.  
FIGURE 1 
Procedures for streamlined digital processing and data protection - FAME 
The FAME process was designed to enable maximum digital management of the study and to 
ensure a simple, smooth experience for participants. Each participant was digitally assigned a 
unique study identifier (USID) through the survey platform upon entry to the consent form. 
The USID is used to link to their unique records on all study data sources. The USID will 
remain the participants’ unique identifier throughout the study and is central to the 
implementation of FAME. All communications with participants are automatically generated 
using their USID to automatically link to their own records. Individual participants' records 
from the consent form, baseline questionnaire, and all follow-up rounds will be matched 
through the USID.  Access to any data or identifying information is protected by secure 
barriers at each level of access (see Figure 2). 
FIGURE 2 
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The Flux Webpage 
All recruitment advertisements and recruitment email invites were directed to the Flux web 
page (http://www.flux.org.au), which provided a detailed description of the study aims, 
requirements for participation, the time required for survey completion, information about 
ethical approval, and study contact information. Once the participant clicked on the “Enrol 
Now” button on the Flux website, they were redirected to the online consent form.     
Online platform 
All study forms are hosted by Survey GizmoTM, an online survey creator with many features 
that permitted us to design customised questionnaires tailored and automated to the specific 
needs of the project. Specifically, this allowed us to confidentially link data using the FAME 
process between study websites, external databases, and study questionnaires. Linking data in 
this way allowed us to maintain separation between information provided on the study 
consent forms and participants’ survey responses.   
Online Consent Form 
Participant confidentiality is strictly maintained at all times. For added protection, the consent 
form and subsequent survey forms were designed as separate online self-complete forms. 
They needed to be digitally linked automatically to minimise processing of individual forms 
and potential errors. The consent and survey forms were created separately, and then digitally 
linked via the FAME process using the digitally generated USID.   
The consent form described the study and explained study requirements and a link back to the 
Flux website if participants wanted more detail. At this point, participants could decide 
whether to join the Flux cohort and agree to six-monthly follow-up surveys, or simply 
complete the baseline survey anonymously.  
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Those participants who chose to complete the baseline questionnaire anonymously were re-
directed into the baseline survey form (by-passing the cohort-specific consent requirements). 
Their USID and consent type were the only items automatically inserted into the baseline 
survey form. Upon completion of the baseline survey form, these non-cohort participants 
were again offered the option to join the Flux cohort with follow-up questionnaires. Those 
indicating an interest in full enrolment were re-directed back into the consent form with their 
USID copied back to the new consent form. A total of 108 participants (20.0%) who initially 
chose to anonymously complete the baseline questionnaire changed their mind at the end of 
the baseline entry to subsequently join the Flux cohort. 
Participants who chose to join the cohort study moved on to the next page of the consent 
form, which listed additional, optional consents for data linkage. Participants were required to 
create a Flux user account to enable ongoing contact with them during the life of the study. 
They were asked to enter their full name, email address, and phone numbers, and their 
preferred method of contact. To further protect the participants’ identity, they were also 
required to create a Flux profile name. The Flux profile name is comprised of the name of 
participants’ first pet and the name of the first street on which they lived. This name was used 
in all communications with the participants.  
Baseline assessment 
Once their Flux account was created, participants could either commence the baseline 
questionnaire immediately or defer until a later time. Participants who deferred their entry 
were automatically emailed a PDF copy of their consent form via the FAME process which 
was addressed to their Flux profile name, and a unique link to their baseline survey form 
[Appendix III]. The link contained the USID which would be pushed into the baseline survey 
form when the link was triggered. These deferring participants were sent an email reminder 
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to complete their questionnaire the following week, also containing their USID and unique 
link to the survey form. This process was automatically executed by the FAME process.  
Participants who chose to immediately proceed to the questionnaire were automatically 
moved to the baseline survey form and FAME would automatically send an email to the 
participant with their consent form and their unique link back into the survey form. By 
clicking this link, participants would automatically return to the point where they left off 
should they close their session, either intentionally or unintentionally. Providing each 
participant with their own unique link prevents duplicated and lost entries.  
Upon entry into the baseline survey form, the participants’ USID and Flux profile name were 
automatically inserted from the consent form into the baseline survey form. No identifying 
details were included in survey forms. 
The baseline questionnaire included 199 questions. All items, where applicable, had non-
response options (i.e., not applicable, none of the above, etc.). Approximately 30% of items 
were deemed key to measuring drug use behaviour over time and were therefore made 
mandatory. At any point, participants have the ability to return to a previous page and change 
their responses. 
Due to the detailed and lengthy nature of the questionnaire, extensive survey logic (adaptive 
questioning) and custom scripts were written so that the baseline survey form was executed 
in a personalised and logical manner. That is, each participant completing the baseline survey 
form experienced a unique pattern based on their previous responses. Irrelevant questions 
were not displayed. For example, if someone had indicated they had never used drugs, all 
other questions about drug use behaviours were skipped. This reduced the number of 
questions displayed to the participant, and the time required for survey completion. This also 
meant that the more experience a participant had with drugs, the longer the questionnaire they 
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experienced. To make this more manageable, the baseline survey form was split into two 
parts: Part A asked about the participants demographics, drug use, and sexual behaviours, and 
part B measured participants’ attitudes. Participants also had the option to save their 
responses to part A and return to part B at a later time. Participants who chose to defer part B, 
automatically received an email via the FAME process, with their unique link which would 
return them to their last point of entry. This feature also prevents duplicated entries. A total of 
51 participants (2.3%) chose to defer entry into part B, of which 36 participants returned to 
complete their entry.  
Upon submitting their final responses, participants received an automatically generated email 
via FAME confirming their completion of the baseline questionnaire.  
Follow-up questionnaires 
Six months after completing the baseline questionnaire, participants were invited to complete 
their first follow-up questionnaire. Invitations were sent by email and an accompanying SMS 
addressed to their Flux profile name. Every participant received an email containing a unique 
link to their personally tailored survey form. Clicking this link redirected them to a welcome 
page. Here, they verify that their USID was correct. Once confirmed, key responses from 
their baseline questionnaire were automatically loaded into the follow-up survey form. Using 
their baseline responses, the follow-up survey form was executed in a unique pattern, 
skipping redundant questions to ensure they were only asked relevant questions. For 
example, if a participant was not using drugs at baseline and reported using drugs at follow-
up, specific questions about those changes in drug using behaviours were displayed. So, 
relevant questions were only asked of those who meet the specific criteria. The follow-up 
questionnaire included 187 questions. 
Study database 
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A separate encrypted and protected study tracking database was specifically designed to track 
participants’ progression throughout the study and store the Flux mailing list. Other than 
participants' own chosen email addresses, no identifying information was included in the 
tracking database and the USID was used to link with participants' own records. 
An export of only the USID, Flux profile name, email address, mobile number and 
completion status, was captured from the consent form and survey forms and downladed into 
theu survey study database. Upon conversion to the study database file, it was stored in a 
protected, designated folder. Whenever the study database was launched, it automatically 
updated the enrollment and completion status for each participant. Complete datasets for each 
of the consent and survey forms are maintained in separate, protected databases. 
To identify which participants were due to be invited or reminded, and on what dates, a query 
was created within the study database, automatically generating a list of only those being 
invited into the next round, or those being reminded about survey completion. Upon 
generation, these lists were uploaded into Survey Gizmo, from where each participant 
received an email uniquely addressed to their Flux profile name, with the link to their survey 
form containing their USID. Upon clicking this link, they were returned to their current 
position in the questionnaire.  
Cohort maintenance 
To maintain a large volunteer online cohort, it is essential to closely monitor participation to 
ensure the accuracy of participants’ contact information, and completion of data. The emails 
sent to participants upon enrollment also provided an opportunity to determine if they had 
provided valid email addresses. Initially, some participants entered incorrect email addresses, 
posing a problem for ongoing participation. A customised email verification was embedded 
into the consent form requiring participants to enter their email address twice. A custom 
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script ensured that participants were unable to proceed unless the two email addresses 
matched. Only two emails bounced during the subsequent seven months of recruitment.  
To prevent duplicate entries, the USID was appended to the end of each survey link, 
disabling that number from being re-used as an entry (regardless of the location or IP 
address). If the link was previously activated, the participant would be sent to the last page 
they had completed. This also provided a user-friendly way for participants to save and 
continue their participation.  
The automated weekly query within the study database identified participants who had not 
completed their responses to each survey round. This process was repeated for ten weeks or 
until each individual participant completed his questionnaire. From the useable responses, 
1576 (92.1%) completed the baseline questionnaire without needing an email or SMS 
reminder. Sixty-three participants completed their response after the first reminder, and 54 
completed after the second reminder; only 18 required subsequent reminders.  
A key aspect of cohort maintenance is to ensure ongoing engagement with, and feedback to, 
study participants. A Flux Facebook page (www.facebook.com/fluxstudy) maintained an 
online public presence for participants. This page posts current events of relevance to the 
Flux study and the latest information about the study. In addition, a quarterly eNewsletter is 
sent to the participants with study developments and findings, milestones, and events.   
Data linkage 
The optional consents were to link participants' responses with external databases. 
Identification  and verification of self-reported baseline and incident HIV infections within 
the cohort will be achieved by linkage to the HIV registry. Linkage with hospital separations 
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will identify drug-related incidents within the cohort. Data linkages will be completed at the 
end of the study period. 
Results 
A total of 2251 participants completed the baseline questionnaire, of whom, 1711 enrolled in 
the prospective observational study with six-monthly follow-up; 540 completed the same 
survey anonymously and declined to participate in the cohort.  
The majority of participants (both enrolled or anonymous) were recruited through Facebook 
targeted advertising (Table 1). About one in six were recruited through popular gay dating 
sites and one in twenty through smartphone dating apps. Small proportions were recruited 
through participants’ own personal networks and gay community organisations or events. 
Most participants identified as cisgender men (99.2%) and there were 17 transgender or 
intersex men (0.8%). The mean age of the sample was 33.0 years (SD 12.6; range 16.6 to 
81.0) however 35.9% were aged less than 25. Most identified as gay or homosexual, but 
about one in twelve identified as bisexual. Only seven identified as heterosexual and a small 
proportion reported other identities such as: Uncategorised, queer, pansexual, bi-curious, 
asexual, and fluid. Men who did not consent to follow-up, and were not enrolled in the cohort 
were younger (p=0.001), and significantly less likely to identify as gay (p<0.001) compared 
to men who consented to follow-up (Table 1).  
TABLE 1 
Over half (50.5%) the men reported that they had used any illicit drug in the previous six 
months. Over a quarter (28.0%) had used party drugs (ecstasy, speed, cocaine, crystal 
methamphetamine, gamma hydroxybutyrate [GHB], ketamine, lysergic acid diethylamide 
[LSD]) in the previous six months. The most common drugs used were marijuana, amyl 
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nitrite, and ecstasy (Table 2). About one in eight men (12.0%) had used crystal 
methamphetamine in the previous six months. Men who did not enroll in the cohort were less 
likely than men who did to have used any of the illicit drugs listed in the previous six months 
(p=0.019). 
TABLE 2 
Among the 1711 men enrolled into the cohort, 1487 (86.9%) had not used crystal 
methamphetamine in the six months prior to enrolment, 1133 (66.2%) had not used amyl 
nitrite, and 1315 (76.9%) had not used erectile dysfunction medication. In total, 790 men 
(46.2%) had used none of these drugs  (Table 3). Among the 540 men who participated 
anonymously, 495 (91.7%) had not used crystal methamphetamine in the six month prior to 
completing the baseline questionnaire, 395 (73.1%) had not used amyl nitrite, and 445 
(82.4%) had not used erectile dysfunction medication. In total, 316 men (58.5%) who 
participated anonymously had used none of these drugs (Table 3).  
TABLE 3 
Discussion 
We have established an entirely online cohort study of incidence and risk factors for 
initiation, cessation, and changes in drug use over time among Australian GBM. The 
characteristics of both the enrolled and the anonymous paricipants in the Flux sample, while 
somewhat younger, are otherwise comparable to those of other samples of Australian GBM 
(Lea et al., 2013b; Prestage et al., 2009a; Zablotska, Holt, & Prestage, 2012). We have 
demonstrated the ability to collect sensitive information while protecting participants' 
confidentiality and that participants will provide valid personal contact details to enable 
successful follow-up. Flux has further demonstrated that it is possible to achieve these 
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outcomes with minimal direct labour costs, by developing the FAME system to digitally link 
study databases, online data collection tools, and communications with study participants. 
Investing in this technical infrastructure facilitates flexible and individually tailored study 
participation. The greater efficiency, ease of participation, and protection of data integrity 
against human error is an advantage compared to non-online cohorts. It also allows 
participants to decide their level of engagement, participation, and flexibility.  
The initial recruitment target, which was based on our sample size calculations, was 
surpassed.  This was achieved due to large enrolments obtained through targeted advertising, 
particularly of younger men.  
As has been found in other samples of GBM (Roxburgh et al., 2015; Zablotska et al., 2012), 
men in this study reported rates of substance use that were substantially higher than in the 
adult male population as a whole. Whereas general population studies have found that about 
one in six (17.3%) adult men report recently using any illicit drug use, with 2.5% using 
recently using crystal methamphetamine (Roxburgh et al., 2015), half (50.5%) of men in the 
Flux study were found to recently use illicit drugs with 12.0% recently using crystal 
methamphetamine. However, in comparison to other convenience samples of Australian 
GBM (Lea et al., 2013b; Prestage et al., 2009a), participants in the Flux study were no more 
likely to report the use of drugs, and in some cases could be described as being somewhat 
less likely. 
The processes and tools developed to administer this entirely online cohort study have 
substantially reduced the workload and resources required for a study of this type. This 
process also provides further protection of confidentiality by minimising the need for direct 
involvement by study staff with individual participants or their data. Participants are able to 
progress through the survey forms, at their own pace and in a setting of their choosing, and 
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there is a smooth transition and carriage of data across survey rounds. Whether the cohort 
includes few or many participants or is a national or international study, the cost and time 
management essentially remains the same when using the FAME system. This has 
contributed to a high completion rate once survey responses were commenced.  
In addition to its high efficiency and minimal staff requirements, the design and execution of 
an online methodology provided many advantages. We were able to conduct a large national 
study in a geographically dispersed country and to attract both men that are engaged and not 
engaged with gay community life (Table 2). Online self-completion protects participant 
confidentiality by minimising direct involvement with study staff.  Similar to Audio 
Computer-Assisted Self-Interview Software (ACASI), the online methodology potentially 
reduces social desirability bias in reporting illegal or stigmatised behaviours (Davis, Couper, 
Janz, Caldwell, & Resnicow, 2010; De Vaus, 2013; Engel & Schutt, 2016). The online 
methodology also provides a streamlined experience for the participants. Questions and 
sections of each survey were tailored to match participants’ previous responses; not just 
within the current round, but also from previous rounds. 
Nonetheless, an entirely online cohort removes direct human interaction with participants. 
The absence of an interviewer also removes the ability for interviewers to clarify and probe 
participant responses (Davis et al., 2010; De Vaus, 2013; Engel & Schutt, 2016). However, as 
this study sought detailed information about sensitive and potentially illegal behaviours, self-
completion in the privacy of their own homes, at their own time and pace, may reduce social 
desirability bias (White, Day, & Maher, 2007).  
This study design meant that there was no opportunity for clinical data collection to verify 
self-reported medical conditions. We will, however, collect information such as drug-related 
hospital admissions, HIV status, and deaths for those who gave consent to data linkage. As 
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with most social and behavioural populations engaged in illicit or stigmatized behaviours, 
whether online or face-to-face, we could not guarantee individuals’ identity. Nonetheless, for 
those consenting to follow-up, we were able to verify a valid email address.  
Conclusions 
Having successfully implemented the FAME system to establish the first entirely online 
cohort study of drug use among Australian GBM, the Flux study will be able to provide data 
on incidence and factors associated with, initiation and cessation, and changes in patterns of 
drug use and related harms over time, among GBM. We will achieve these outcomes at a 
significantly reduced cost compared to traditional cohort studies while maintaining high 
levels of participant engagement and confidentiality at all stages. The high rates of illicit drug 
use in this sample indicate the need for longitidual enqiry and follow up to assess continuing 
and changing patterns of drug use over time within this population. 
Funding Source Declaration  
This study was funded by the Australian Research Council (ARC). ARC grant number: 
RG132750. The Kirby Institute and Centre for Social Research in Health receive funding 
from the Australian Government Department of Health. The National Drug and Alcohol 
Research Centre, UNSW is supported by funding from the Australian Government under the 
Substance Misuse Prevention and Service Improvements Grants Fund. Lisa Maher is 
supported by a National Health and Medical Research Council Senior Research Fellowship. 
Louisa Degenhardt is supported by an Australian National Health and Medical Research 
Council (NHMRC) Principal Research Fellowship. 
Author Agreement/Declaration  
 22 
All authors certify that they have seen and approved the final version of the manuscript being 
submitted. All authors warrant that the article is the authors' original work, hasn't received 
prior publication and isn't under consideration for publication elsewhere.   
 23 
 
Table 1: Characteristics of the sample 
 Enrolled full 
cohort 
participants 
n=1711 (76.0) 
n (%) 
Anonymous 
baseline only 
participants 
n=540 (24.0)
n (%) 
Total 
N=2251 
N (%) 
Mean age in years (SD) ** 33.7 (12.5) 30.9 (12.6) 33.0 (12.6) 
Sexual orientation *** 
Gay 1544 (90.2) 446 (82.6) 1990 (88.4) 
Bisexual 122 (7.1) 77 (14.3) 199 (8.8) 
Heterosexual 2 (0.1) 5 (0.9) 7 (0.3) 
Other 43 (2.5) 12 (2.2) 55 (2.4) 
Recruitment Source ** 
Social media (Facebook) 1137 (66.5) 341 (63.1) 1478 (65.7) 
Dating site (Manhunt/Squirt) 293 (17.1) 100 (18.5) 393 (17.5) 
Phone apps (Grindr/Jack’d) 69 (4.0) 43 (8.0) 112 (5.0) 
Personal networks 81 (4.7) 24 (4.4) 105 (4.6) 
Gay community organisations 43 (2.5) 6 (1.1) 49 (2.2) 
Community events (Fair day) 20 (1.2) 7 (1.3) 27 (1.2) 
Other 68 (4.1) 19 (3.6) 87 (3.9) 
Geographical location * 
New South Wales 697 (40.7) 198 (36.7) 985 (39.8) 
Victoria 428 (25.0) 135 (25.0) 563 (25.0) 
Queensland 265 (15.5) 91 (16.9) 356 (15.8) 
Northern Territory 12 (0.7) 5 (0.9) 17 (0.8) 
Western Australia 118 (3.9) 34 (6.3) 152 (6.8) 
South Australia 99 (5.8) 42 (7.8) 141 (6.3) 
Australian Capital Territory 67 (3.9) 12 (2.2) 79 (3.5) 
Tasmania 18 (1.1) 15 (2.8) 33 (1.5) 
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Overseas 5 (0.3) 4 (0.7) 9 (0.4) 
Did not answer 2 (0.1) 4 (0.7) 6 (0.3) 
 
*p<.05  **p<.01 ***p<.001 
 
 
Table 2: Use of illicit drugs in previous six months 
 Enrolled full cohort 
participants n=1711 
(76.0) 
n (%) 
Anonymous 
baseline only 
participants n=540 
(24.0) 
n (%) 
Total 
N=2251 
N (%) 
Cannabis 522 (30.5) 140 (25.9) 662 (29.4) 
Amyl nitrite 578 (33.8) 145 (26.9) 723 (32.1) 
Ecstasy 329 (19.2) 69 (12.8) 398 (17.7) 
Meth/amphetamine 
(speed) 
109 (6.4) 26 (4.8) 135 (6.0) 
Cocaine 229 (13.4) 52 (9.6) 281 (12.5) 
Lysergic acid 
diethylamide (LSD) 
72 (4.2) 9 (1.7) 81 (3.6) 
Crystal 
methamphetamine  
224 (13.1) 45 (8.3) 269 (12.0) 
Ketamine 74 (4.3) 11 (2.0) 85 (3.8) 
Gamma hydroxybutyrate 
(GHB) 
132 (7.7) 24 (4.4) 156 (6.9) 
Heroin 3 (0.2) 0 (0.0) 3 (0.1) 
 
 
Table 3: Combined use of crystal methamphetamine, EDM, and amyl nitrite 
 Enrolled full cohort 
participants n=1711 
(76.0) 
n (%) 
Anonymous 
baseline only 
participants n=540 
(24.0) 
n (%) 
Total 
N=2251 
N (%) 
Used crystal 
methamphetamine only 
26 (1.5) 4 (0.7) 30 (1.3) 
Used erectile dysfunction 
medication only 
289 (16.9) 65 (12.0) 354 (15.7) 
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Used amyl nitrite only 252 (14.7) 75 (13.9) 327 (14.5) 
Used crystal 
methamphetamine + 
erectile dysfunction 
medication 
28 (1.6) 10 (1.9) 38 (1.7) 
Used crystal 
methamphetamine + 
amyl nitrite 
30 (1.8) 9 (1.7) 39 (1.7) 
Used erectile dysfunction 
medication + amyl nitrite 
156 (9.1) 39 (7.2) 195 (8.7) 
Used all three 140 (8.2) 22 (4.1) 162 (7.2) 
Used none 790 (46.2) 316 (58.5) 1106 (49.1) 
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Figure 1: Flux study pathway  
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Figure 2: The FAME Process 
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